Saudi Chemical Holding Company (TADAWUL:2230)

Market Cap	7.17B +5.2%
Revenue (ttm)	6.96B +9.3%
Net Income	340.20M +20.6%
EPS	0.40 +20.6%
Shares Out	843.20M
PE Ratio	21.07
Forward PE	n/a
Dividend	0.10 (1.18%)
Ex-Dividend Date	May 14, 2026

Volume	4,892,324
Open	8.49
Previous Close	8.49
Day's Range	8.46 - 8.61
52-Week Range	6.06 - 8.98
Beta	0.25
Analysts	Strong Buy
Price Target	3.45 (-59.41%)
Earnings Date	Aug 6, 2026

About TADAWUL:2230

Saudi Chemical Holding Company engages in the manufacture, distribution, and retail of medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools and equipment, supplies of hospitals and medical centers and its related spare parts, and food products. The company operates through three segments: Explosives; Medicine and Medical Supplies; and Production of Ammonium Nitrate. It also manufactures and sells explosives and related products for civilian and military use; provides technical support services in expl...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1972
• Employees: 330
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 2230

Financial Performance

In 2025, TADAWUL:2230's revenue was 6.88 billion, an increase of 7.93% compared to the previous year's 6.38 billion. Earnings were 335.32 million, an increase of 15.13%.